Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 55 for genomics

Edit search filters
  1. A Study on Mayo Clinic Patients with Friedreich Ataxia

    Rochester, MN

  2. A Study to Explore Clinicians’ Point-Of-Care Decision-Making Process and Behavior following a Pharmacogenomics Alert

    Rochester, MN

  3. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders

    Rochester, MN

  4. Visual Outcomes in Patients with Neurofibromatosis Type 1

    Rochester, MN

  5. Clinical and Basic Investigations into Congenital Disorders of Glycosylation

    Rochester, MN

  6. A Study to Analyze the Microbiome and Immunology of the Lower and Upper Female Reproductive Tract in Women with Endometriosis

    Rochester, MN

  7. AEBP1 Fibroblast Study

    Jacksonville, FL

  8. A Study to Evaluate Return of Pharmacogenomic Results Through Direct-to-Consumer Online Portal: Consumer Experiences

    Rochester, MN

  9. Analyzing Whether Pharmacogenetics in Psychiatric Patients with Polypharmacy Can Identify Increased Medication Adverse Effects and Improve Outcomes

    Rochester, MN

  10. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer